Table:
begin	end	state
1	29	cytoplasmic
30	52	transmembrane
53	63	non-cytoplasmic
64	87	transmembrane
88	93	cytoplasmic
94	116	transmembrane
117	127	non-cytoplasmic
128	152	transmembrane
153	154	cytoplasmic
155	176	transmembrane
177	188	non-cytoplasmic
189	217	transmembrane
218	244	cytoplasmic
245	267	transmembrane
268	277	non-cytoplasmic
278	297	transmembrane
298	303	cytoplasmic
304	324	transmembrane
325	330	non-cytoplasmic
331	350	transmembrane
351	359	cytoplasmic

Input:
>HSERO_RS05180
MSASMDSKLIPDTAASAGSPMLAGLLRHPLVRPLGALAVLLLIDFLLVPGFFKLEIKDGH
LYGALIDIINRAAPLMLAALGMTLVIATRGVDISVGAVVAISGAVAAILIGGKMVVVDGV
SQYVSNVPMVWALCAAMGAALLCGAWNGLLVAGLGLQPIIATLILMVAGRGLAQLLTDGQ
IVTVYYKPFFFLGGGYLFGLPFSLYIAAAMFVLLALLMKKTALGLFIESVGINPVASRLA
GIRTAALIFFVYMFCSACAGLAGLMIASNIKSADANNAGLLLELDAILAVTLGGTSLAGG
KFSLVGSVIGALIIQTLTYTIYSLGVPPEVNMVVKSIVVFLVCLSQSPQFRRMLRMSKS

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server